WO1994023777A1 - Intradermal injection device - Google Patents

Intradermal injection device Download PDF

Info

Publication number
WO1994023777A1
WO1994023777A1 PCT/IE1994/000020 IE9400020W WO9423777A1 WO 1994023777 A1 WO1994023777 A1 WO 1994023777A1 IE 9400020 W IE9400020 W IE 9400020W WO 9423777 A1 WO9423777 A1 WO 9423777A1
Authority
WO
WIPO (PCT)
Prior art keywords
piston
vacuum
skin
penetrating
medicament
Prior art date
Application number
PCT/IE1994/000020
Other languages
French (fr)
Inventor
Joseph Gross
John Gerard Kelly
Original Assignee
Elan Medical Technologies Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Medical Technologies Limited filed Critical Elan Medical Technologies Limited
Priority to JP6522956A priority Critical patent/JPH08508901A/en
Priority to EP94912055A priority patent/EP0692989A1/en
Priority to AU64367/94A priority patent/AU6436794A/en
Publication of WO1994023777A1 publication Critical patent/WO1994023777A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/42—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
    • A61M5/425—Protruding skin to facilitate piercing, e.g. vacuum cylinders, vein immobilising means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/281—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
    • A61M5/282—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by compression of deformable ampoule or carpule wall
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3295—Multiple needle devices, e.g. a plurality of needles arranged coaxially or in parallel
    • A61M5/3298—Needles arranged in parallel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion

Definitions

  • This invention relates to a device for administering intradermally a medicament in liquid form.
  • intradermal herein is intended to embrace subcutaneous.
  • medicaments Many drugs, active ingredients or medications, hereinafter referred to collectively as medicaments, require administration by injection. This mode of administration tends to be inconvenient and also painful. Patients may be required to self-administer a medicament, such as insulin in the case of diabetics, and various attempts have been made to make this mode of administration more convenient, thereby, increasing patient compliance. Thus, "pen” type injectors have been proposed.
  • Such a device should ideally include a needle or needles which enter the skin to a predetermined depth and allow precise penetration of the skin by the patient.
  • the invention provides a device for administering intradermally a metered dose of a medicament in liquid form, said device comprising means for creating a vacuum so as to secure the device to the skin during medicament delivery, means for penetrating one or more skin layers and delivering said metered dose and means for releasing said vacuum for removal of the device following delivery of the metered dose.
  • the device according to the invention can be used with a minimum of trauma by patients as well as by medical and nursing staff, to administer a range of medicaments, including peptides and polypeptides, by the intradermal route as hereinbefore defined.
  • the means for creating the vacuum comprises a piston arrangement and an associated system of air channels.
  • the means for penetrating the or each skin layer comprises a plurality of hollow needles in communication with a reservoir for the medicament.
  • the creation of the vacuum can cause the skin to be drawn towards, and penetrated by, said penetration means.
  • the vacuum is created circumferentially of the penetrating means.
  • the vacuum can be generated circumferentially of a housing for the device.
  • the penetrating means comprises a plurality of hollow needles
  • a vacuum can be created circumferentially of each needle defining said penetrating means.
  • the piston arrangement when such is present, is preferably actuated by a plunger mechanism integral with the piston.
  • the piston impinges on a displaceable membrane defining a boundary wall of the reservoir so as to expel the contents of the reservoir through the penetrating means when the piston is depressed.
  • the plunger has an internal air duct which is open to the atmosphere.
  • the penetrating means can be movable within the device, such that when the vacuum is generated, said penetrating means is simultaneously or sequentially displaced towards the skin for penetration thereof.
  • actuation of the device simultaneously creates the vacuum and causes movement of the skin penetrating means for penetration of the skin.
  • the vacuum generated can draw the skin against a plate structure in the device disposed on a skin-contacting surface thereof.
  • the plate structure then maintains the skin in position while a set of needles is caused to descend and pass through a plurality of apertures in said plate structure and enter the skin to a predetermined depth.
  • a set of needles is fixed in position on such a plate structure and the act of drawing the skin against the plate causes the needles to penetrate the skin.
  • the medicament is then delivered as a single dose through the set of needles.
  • the withdrawal of the needles from the skin can release the vacuum or vice versa.
  • the device according to the invention is preferably in the form of a disposable pre-filled product for once-off use, although the device can be readily adapted for continued use by the provision of filling means for replenishing the reservoir.
  • the device is suitably provided with means for indicating when a quantity, corresponding to one or more metered doses, has been inserted therein.
  • the medicament can have almost any viscosity, provided that it can be dispensed through the penetrating means at a rate which is pharmaceutically effective and acceptable.
  • the penetrating means will suitably be manufactured from medical-grade stainless steel.
  • the penetrating means can also be composed of a suitable inert plastics material.
  • the device according to the invention is suitable for the administration, including self-administration, of a wide range of medicaments, including peptides and polypeptides.
  • the device according to the invention is especially suitable for the administration of insulin.
  • the device according to the invention is also suitable for the administration of vaccines in methods of vaccination.
  • the device according to the invention can be used to inject a medicament intradermally or subcutaneously automatically as desired by suitable adjustment of the length of the needles or the extent to which the needles or other penetrating means are movable relative to or within the device.
  • the device according to the invention allows for precise penetration of the skin which is an advantage over currently available automatic injection devices.
  • the device according to the invention can also be used to inject controlled release formulations, suitably in a lipophilic base, allowing for convenient subcutaneous injection of depot formulations.
  • the device may be enclosed in a sterilised package until required for use.
  • the needles or other penetrating means will normally be either covered by a peel-off strip or stuck in an impermeable pad to prevent the medicament from leaking out of the device while in storage.
  • Fig.l is a front elevation in section of a first embodiment of the device according to the invention.
  • Fig. 2 is a plan view of the device of Fig. 1 taken on the line II-II;
  • Fig. 3 is a front elevation in section of a second embodiment of the device according to the invention.
  • Fig. 4 is a plan view of the device of Fig. 3 in the direction of the arrow.
  • a device for administering intradermally to a patient a metered dose of a medicament in liquid form comprising a housing 11 and a piston arrangement, indicated generally at 12, comprising a piston 13 movable in sealing engagement within a hollow chamber 14 disposed internally of the housing 11.
  • the piston 13 is provided with an integral plunger mechanism 15 for actuation by the person administering the medicament.
  • the plunger 15 has an internal airway 16 which is substantially L-shaped and which communicates with the atmosphere via an outlet 17.
  • End 18 of the piston 13, which travels within the chamber 14, serves to close the end of the chamber 14 distal from the skin, in use, apart from a second outlet 19 of the airway 16.
  • the end of the chamber 14 proximal to the skin, in use is defined by an elastomeric membrane 20 defining a boundary wall 21 of a reservoir 22 for the medicament 23.
  • the piston arrangement 12 is similar to that used in a conventional hypodermic syringe and thus end 18 of piston 13 which travels within chamber 14 has a circumferentially extending flexible grooved sealing means.
  • the housing 1 1 has a cap 24 with an aperture 25 through which shaft 26 of the plunger mechanism 15 passes in sealing engagement therewith.
  • An air chamber 27 which communicates via extension 28 with the space above end 18 of the piston 13 when the piston is depressed is disposed intermediate walls 29 of the housing 11 and the walls of the chamber 14 and is continuous within a skin-contacting part 30 of the housing 11 containing penetrating means 31 comprised of a plurality of needles 32.
  • the air chamber 27 is also in communication with an aperture 33 surrounding each needle 32.
  • the air chamber 27 can be replaced by a plurality of narrow bore air chambers, typically four, spaced equidistantly about the circumference of the device 10 and being continuous with the space above end 18 of the piston 13 when the piston is depressed and with the skin-contacting part 30.
  • the device 10 is provided with a circumferentially extending elastomeric sealing ring 34 for engagement with the skin in use.
  • the person administering the medicament who may be the patient, selects the site on the skin at which the medicament is to be administered.
  • the device 10 is applied to the skin, the plunger mechanism 15 is depressed in the direction of the skin, causing the piston 13 to move towards the membrane 21.
  • the hollow chamber 14 is open to the atmosphere via outlet 17. Depression of the piston 13 causes a reduction in pressure in space 28 and causes air to be sucked into said space via the air chamber 27, resulting in the creation of a vacuum at the site of application of the device 10.
  • the creation of the vacuum causes the skin to be drawn towards and penetrated by the needles 32.
  • the medicament 23 is delivered through the needles 32 in response to the action of the piston 13 depressing the membrane 20 which forces the medicament 23 out of the reservoir 22 and into the needles 32 followed by intradermal delivery.
  • the piston 13 is retracted releasing the vacuum and thereby releasing the device 10.
  • FIG. 3 and 4 of the Drawings there is illustrated a modification of the device 10 depicted in Fig. 1 and wherein like parts are accorded like reference numerals.
  • the hollow chamber 14' and the skin-contacting part 30' each has a slightly different shape relative to the hollow chamber 14 and the skin-contacting part 30, respectively, of the embodiment depicted in Fig. 1.
  • the membrane 20' in situ has a shape dictated by the interengaging parts 14' and 30'.
  • a peripherally-extending flange 35 which, in use, rests on the skin (not shown).
  • An air chamber 27' is formed intermediate walls 29' of the housing 1 1 and externally of the hollow chamber 14' and the skin- contacting part 30'.
  • the needles 32 are not each provided with an aperture in contact with the air chamber 27'. Rather, when the flange 35 engages the skin, in use, and the piston 13 is depressed, air is sucked from the air chamber 27' into space 28 above piston 13, so as to create a vacuum circumferentially and externally of the part of the device 10 housing the needles 32. The creation of the vacuum causes the device 10 to be held firmly in contact with the skin during delivery of the medicament. To release the device 10, the piston 13 is retracted in the same manner as for the embodiment depicted in Fig. 1.

Abstract

A device (10) for administering, including self-administering, a metered dose of a liquid medicament (23) intradermally or subcutaneously comprises means (12, 27', 30', 35) for creating a vacuum so as to secure the device (10) to the skin during medicament delivery, means (32) for penetrating one or more skin layers to a desired depth and delivering the medicament and means (12, 27', 30', 35) for releasing the vacuum for removal of the device (10) following medicament delivery. The device (10) can be in the form of a disposable, pre-filled product for once-off use. The device (10) provides a convenient method of medicament delivery for increasing patient compliance.

Description

Description
INTRADERMAL INJECTION DEVICE
Technical Field
This invention relates to a device for administering intradermally a medicament in liquid form.
The use of the term "intradermal" herein is intended to embrace subcutaneous.
Background Art
Many drugs, active ingredients or medications, hereinafter referred to collectively as medicaments, require administration by injection. This mode of administration tends to be inconvenient and also painful. Patients may be required to self-administer a medicament, such as insulin in the case of diabetics, and various attempts have been made to make this mode of administration more convenient, thereby, increasing patient compliance. Thus, "pen" type injectors have been proposed.
There is a need for a device which can be used to automatically inject a metered dose of a medicament intradermally with the minimum of trauma. Such a device should ideally include a needle or needles which enter the skin to a predetermined depth and allow precise penetration of the skin by the patient.
Disclosure of the Invention
The invention provides a device for administering intradermally a metered dose of a medicament in liquid form, said device comprising means for creating a vacuum so as to secure the device to the skin during medicament delivery, means for penetrating one or more skin layers and delivering said metered dose and means for releasing said vacuum for removal of the device following delivery of the metered dose.
The device according to the invention can be used with a minimum of trauma by patients as well as by medical and nursing staff, to administer a range of medicaments, including peptides and polypeptides, by the intradermal route as hereinbefore defined.
Preferably, the means for creating the vacuum comprises a piston arrangement and an associated system of air channels.
Further, preferably, the means for penetrating the or each skin layer comprises a plurality of hollow needles in communication with a reservoir for the medicament.
The creation of the vacuum can cause the skin to be drawn towards, and penetrated by, said penetration means.
In one embodiment, the vacuum is created circumferentially of the penetrating means. For example, the vacuum can be generated circumferentially of a housing for the device.
In the case when the penetrating means comprises a plurality of hollow needles, a vacuum can be created circumferentially of each needle defining said penetrating means.
The piston arrangement, when such is present, is preferably actuated by a plunger mechanism integral with the piston. Further, preferably, the piston impinges on a displaceable membrane defining a boundary wall of the reservoir so as to expel the contents of the reservoir through the penetrating means when the piston is depressed. Further, preferably, the plunger has an internal air duct which is open to the atmosphere. When it is desired to release the vacuum and, thereby, the device from the skin of a patient following administration of the medicament, the piston is retracted.
The penetrating means can be movable within the device, such that when the vacuum is generated, said penetrating means is simultaneously or sequentially displaced towards the skin for penetration thereof.
According to a preferred embodiment, actuation of the device simultaneously creates the vacuum and causes movement of the skin penetrating means for penetration of the skin.
For example, following application of the device to the skin and actuation thereof, the vacuum generated can draw the skin against a plate structure in the device disposed on a skin-contacting surface thereof. The plate structure then maintains the skin in position while a set of needles is caused to descend and pass through a plurality of apertures in said plate structure and enter the skin to a predetermined depth.
Alternatively, a set of needles is fixed in position on such a plate structure and the act of drawing the skin against the plate causes the needles to penetrate the skin. The medicament is then delivered as a single dose through the set of needles.
The withdrawal of the needles from the skin can release the vacuum or vice versa.
The device according to the invention is preferably in the form of a disposable pre-filled product for once-off use, although the device can be readily adapted for continued use by the provision of filling means for replenishing the reservoir. In the case of a refillable device, the device is suitably provided with means for indicating when a quantity, corresponding to one or more metered doses, has been inserted therein. The medicament can have almost any viscosity, provided that it can be dispensed through the penetrating means at a rate which is pharmaceutically effective and acceptable.
The penetrating means will suitably be manufactured from medical-grade stainless steel. However, the penetrating means can also be composed of a suitable inert plastics material.
Other parts of the device may also be manufactured from suitable plastics materials.
The device according to the invention is suitable for the administration, including self-administration, of a wide range of medicaments, including peptides and polypeptides. The device according to the invention is especially suitable for the administration of insulin.
The device according to the invention is also suitable for the administration of vaccines in methods of vaccination.
The device according to the invention can be used to inject a medicament intradermally or subcutaneously automatically as desired by suitable adjustment of the length of the needles or the extent to which the needles or other penetrating means are movable relative to or within the device.
The device according to the invention allows for precise penetration of the skin which is an advantage over currently available automatic injection devices.
The device according to the invention can also be used to inject controlled release formulations, suitably in a lipophilic base, allowing for convenient subcutaneous injection of depot formulations.
The device may be enclosed in a sterilised package until required for use. Furthermore, the needles or other penetrating means will normally be either covered by a peel-off strip or stuck in an impermeable pad to prevent the medicament from leaking out of the device while in storage.
The invention will be further illustrated by the following description of embodiments thereof given by way of example only with reference to the accompanying Drawings in which like parts are indicated by like reference numerals.
Brief Description of the Drawings
In the accompanying Drawings:
Fig.l is a front elevation in section of a first embodiment of the device according to the invention;
Fig. 2 is a plan view of the device of Fig. 1 taken on the line II-II;
Fig. 3 is a front elevation in section of a second embodiment of the device according to the invention; and
Fig. 4 is a plan view of the device of Fig. 3 in the direction of the arrow.
Modes for Carrying Out the Invention
Referring to Figs. 1 and 2 of the Drawings, there is indicated generally at 10, a device for administering intradermally to a patient a metered dose of a medicament in liquid form. The device 10 comprises a housing 11 and a piston arrangement, indicated generally at 12, comprising a piston 13 movable in sealing engagement within a hollow chamber 14 disposed internally of the housing 11. The piston 13 is provided with an integral plunger mechanism 15 for actuation by the person administering the medicament. The plunger 15 has an internal airway 16 which is substantially L-shaped and which communicates with the atmosphere via an outlet 17. End 18 of the piston 13, which travels within the chamber 14, serves to close the end of the chamber 14 distal from the skin, in use, apart from a second outlet 19 of the airway 16. The end of the chamber 14 proximal to the skin, in use, is defined by an elastomeric membrane 20 defining a boundary wall 21 of a reservoir 22 for the medicament 23.
The piston arrangement 12 is similar to that used in a conventional hypodermic syringe and thus end 18 of piston 13 which travels within chamber 14 has a circumferentially extending flexible grooved sealing means.
The housing 1 1 has a cap 24 with an aperture 25 through which shaft 26 of the plunger mechanism 15 passes in sealing engagement therewith.
An air chamber 27 which communicates via extension 28 with the space above end 18 of the piston 13 when the piston is depressed is disposed intermediate walls 29 of the housing 11 and the walls of the chamber 14 and is continuous within a skin-contacting part 30 of the housing 11 containing penetrating means 31 comprised of a plurality of needles 32. The air chamber 27 is also in communication with an aperture 33 surrounding each needle 32.
The air chamber 27 can be replaced by a plurality of narrow bore air chambers, typically four, spaced equidistantly about the circumference of the device 10 and being continuous with the space above end 18 of the piston 13 when the piston is depressed and with the skin-contacting part 30.
The device 10 is provided with a circumferentially extending elastomeric sealing ring 34 for engagement with the skin in use.
In use, when it is desired to administer a liquid medicament such as insulin, the person administering the medicament, who may be the patient, selects the site on the skin at which the medicament is to be administered. The device 10 is applied to the skin, the plunger mechanism 15 is depressed in the direction of the skin, causing the piston 13 to move towards the membrane 21.
The hollow chamber 14 is open to the atmosphere via outlet 17. Depression of the piston 13 causes a reduction in pressure in space 28 and causes air to be sucked into said space via the air chamber 27, resulting in the creation of a vacuum at the site of application of the device 10. The creation of the vacuum causes the skin to be drawn towards and penetrated by the needles 32. As the plunger is fully depressed, the medicament 23 is delivered through the needles 32 in response to the action of the piston 13 depressing the membrane 20 which forces the medicament 23 out of the reservoir 22 and into the needles 32 followed by intradermal delivery. To release the device 10 from the skin (not shown) following medicament delivery, the piston 13 is retracted releasing the vacuum and thereby releasing the device 10.
Best Mode for Carrying Out the Invention
Referring to Figs. 3 and 4 of the Drawings there is illustrated a modification of the device 10 depicted in Fig. 1 and wherein like parts are accorded like reference numerals.
The hollow chamber 14' and the skin-contacting part 30' each has a slightly different shape relative to the hollow chamber 14 and the skin-contacting part 30, respectively, of the embodiment depicted in Fig. 1. Likewise, the membrane 20' in situ has a shape dictated by the interengaging parts 14' and 30'.
In addition to skin-contacting part 30', there is also provided a peripherally-extending flange 35 which, in use, rests on the skin (not shown). An air chamber 27' is formed intermediate walls 29' of the housing 1 1 and externally of the hollow chamber 14' and the skin- contacting part 30'. In the embodiment of Fig. 3, the needles 32 are not each provided with an aperture in contact with the air chamber 27'. Rather, when the flange 35 engages the skin, in use, and the piston 13 is depressed, air is sucked from the air chamber 27' into space 28 above piston 13, so as to create a vacuum circumferentially and externally of the part of the device 10 housing the needles 32. The creation of the vacuum causes the device 10 to be held firmly in contact with the skin during delivery of the medicament. To release the device 10, the piston 13 is retracted in the same manner as for the embodiment depicted in Fig. 1.

Claims

Claims: -
1. A device for administering intradermally a metered dose of a medicament in liquid form, said device comprising means for creating a vacuum so as to secure the device to the skin during medicament delivery, means for penetrating one or more skin layers and delivering said metered dose and means for releasing said vacuum for removal of the device following delivery of the metered dose.
2. A device according to Claim 1, wherein the means for creating the vacuum comprises a piston arrangement and an associated system of air channels.
3. A device according to Claim 1 or 2, wherein the means for penetrating the or each skin layer comprises a plurality of hollow needles in communication with a reservoir for the medicament.
4. A device according to Claim 3, wherein the creation of the vacuum causes the skin to be drawn towards, and penetrated by, the needles.
5. A device according to any preceding claim, wherein the vacuum is created circumferentially of the penetrating means.
6. A device according to Claim 4, wherein a vacuum is created circumferentially of each needle defining said penetration means.
7. A device according to any one of Claims 2 and 3-6 when dependent on Claim 2, wherein the piston arrangement is actuated by a plunger mechanism integral with the piston.
8. A device according to Claim 7 when dependent on Claim
3, wherein the piston impinges on a displaceable membrane defining a boundary wall of the reservoir so as to expel the contents of the reservoir through the penetrating means when the piston is depressed.
9. A device according to Claim 8, wherein the piston and plunger arrangement has an internal air duct which is open to the atmosphere.
10. A device according to Claim 8 or 9, wherein the piston is retracted so as to release said vacuum.
1 1. A device according to any preceding claim, wherein the means for penetrating the or each skin layer is moveable within the device.
12. A device according to Claim 11 when dependent on Claim 2, wherein actuation of the piston causes movement of the means for penetrating the skin.
PCT/IE1994/000020 1993-04-08 1994-04-07 Intradermal injection device WO1994023777A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP6522956A JPH08508901A (en) 1993-04-08 1994-04-07 Intradermal injection device
EP94912055A EP0692989A1 (en) 1993-04-08 1994-04-07 Intradermal injection device
AU64367/94A AU6436794A (en) 1993-04-08 1994-04-07 Intradermal injection device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE930274 1993-04-08
IE930274A IE68890B1 (en) 1993-04-08 1993-04-08 Intradermal delivery device

Publications (1)

Publication Number Publication Date
WO1994023777A1 true WO1994023777A1 (en) 1994-10-27

Family

ID=11039936

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IE1994/000020 WO1994023777A1 (en) 1993-04-08 1994-04-07 Intradermal injection device

Country Status (7)

Country Link
EP (1) EP0692989A1 (en)
JP (1) JPH08508901A (en)
AU (1) AU6436794A (en)
CA (1) CA2159588A1 (en)
IE (1) IE68890B1 (en)
NZ (1) NZ263619A (en)
WO (1) WO1994023777A1 (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983136A (en) * 1996-09-17 1999-11-09 Deka Products Limited Partnership System for delivery of drugs by transport
EP1104683A1 (en) * 1999-12-03 2001-06-06 Mattern, Udo Device for the injection of antiparasitic agents into pet animals
WO2001091846A2 (en) * 2000-05-26 2001-12-06 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
EP1161961A1 (en) * 2000-06-08 2001-12-12 Avant Drug Delivery Systems, Inc. Jet injector
EP1208858A1 (en) * 2000-11-27 2002-05-29 Paolo Versini Injector device for medical and cosmetic treatment
US6465709B1 (en) 1999-07-08 2002-10-15 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
WO2002081014A1 (en) * 2001-04-06 2002-10-17 Glaxosmithkline Biologicals S.A. Hypodermic needle assembly
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
WO2003037407A1 (en) * 2001-10-26 2003-05-08 Massachusetts Institute Of Technology Transdermal transport device with suction
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6591124B2 (en) 2001-05-11 2003-07-08 The Procter & Gamble Company Portable interstitial fluid monitoring system
US6652478B1 (en) 1999-06-09 2003-11-25 The Procter & Gamble Company Intracutaneous edged microneedle apparatus
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
WO2004024211A2 (en) * 2002-09-12 2004-03-25 Children's Hospital Medical Center Method and device for painless injection of medication
US6821281B2 (en) 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US6931277B1 (en) 1999-06-09 2005-08-16 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
US7670314B2 (en) 2004-02-17 2010-03-02 Children's Hospital Medical Center Injection device for administering a vaccine
US7722595B2 (en) 2002-05-06 2010-05-25 Becton, Dickinson And Company Method and device for controlling drug pharmacokinetics
US7828827B2 (en) 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
EP2314282A2 (en) * 2003-10-24 2011-04-27 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
WO2013113121A1 (en) * 2012-01-31 2013-08-08 Trichoscience Innovations Inc. Injection devices
WO2014004462A1 (en) * 2012-06-25 2014-01-03 Flugen, Inc. Multiple drug delivery device
WO2014143770A1 (en) * 2013-03-15 2014-09-18 Amgen Inc. Body contour adaptable autoinjector device
US8900186B2 (en) 2001-09-12 2014-12-02 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
CN104524669A (en) * 2015-01-14 2015-04-22 李洪湘 Multi-syringe-needle adsorption injection needle
US9114238B2 (en) 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
WO2016112361A1 (en) * 2015-01-08 2016-07-14 University Of Washington Systems and methods for inhibiting heterotopic ossification
US9682198B2 (en) 2003-08-28 2017-06-20 Becton, Dickinson And Company Intradermal injection device
US9687641B2 (en) 2010-05-04 2017-06-27 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
CN107213537A (en) * 2017-08-01 2017-09-29 上海市第人民医院 It is a kind of that servicing unit is precisely subcutaneously injected
EP2608824A4 (en) * 2010-08-23 2017-11-08 Nanbu Plastics Co., Ltd. A percutaneous medication device and a needle formation used for the device
US9962534B2 (en) 2013-03-15 2018-05-08 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
AU2016220141B2 (en) * 2015-02-17 2018-07-12 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
US10195409B2 (en) 2013-03-15 2019-02-05 Corium International, Inc. Multiple impact microprojection applicators and methods of use
US10245422B2 (en) 2013-03-12 2019-04-02 Corium International, Inc. Microprojection applicators and methods of use
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
US10384046B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
TWI674121B (en) * 2018-08-30 2019-10-11 員全股份有限公司 Mini micro needle syringe
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
US10675452B2 (en) 2014-03-10 2020-06-09 3M Innovative Properties Company Micro-needle device
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11045612B2 (en) 2014-08-06 2021-06-29 Replicel Life Sciences Inc. Injection devices
US11052231B2 (en) 2012-12-21 2021-07-06 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
US11129945B2 (en) 2016-06-06 2021-09-28 Sanofi-Aventis Deutschland Gmbh Auto-injector device

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2269639B1 (en) * 2001-02-23 2018-11-28 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
JP2005087520A (en) * 2003-09-18 2005-04-07 Terumo Corp Liquid medicine injector
JP6037722B2 (en) * 2012-08-27 2016-12-07 南部化成株式会社 Needle

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB371305A (en) * 1931-10-30 1932-04-21 Mario Demarchi Improvements in syringes for hypodermic medical injections
US2743723A (en) * 1954-06-03 1956-05-01 George N Hein Hypodermic injection apparatus
GB992424A (en) * 1961-03-20 1965-05-19 Vacuum Extractor Ab Improvements in instruments for insertion of contrast fluids for x-ray examination in fistulas
FR2041605A5 (en) * 1969-02-21 1971-01-29 Shozo Narusawa
DE3019589A1 (en) * 1974-11-19 1981-01-15 Wolfgang Dr.Med. 1000 Berlin Wagner Suction syringe has membrane pierced by hollow needle - after suction cut placed on skin and cover rotated

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB371305A (en) * 1931-10-30 1932-04-21 Mario Demarchi Improvements in syringes for hypodermic medical injections
US2743723A (en) * 1954-06-03 1956-05-01 George N Hein Hypodermic injection apparatus
GB992424A (en) * 1961-03-20 1965-05-19 Vacuum Extractor Ab Improvements in instruments for insertion of contrast fluids for x-ray examination in fistulas
FR2041605A5 (en) * 1969-02-21 1971-01-29 Shozo Narusawa
DE3019589A1 (en) * 1974-11-19 1981-01-15 Wolfgang Dr.Med. 1000 Berlin Wagner Suction syringe has membrane pierced by hollow needle - after suction cut placed on skin and cover rotated

Cited By (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983136A (en) * 1996-09-17 1999-11-09 Deka Products Limited Partnership System for delivery of drugs by transport
US6931277B1 (en) 1999-06-09 2005-08-16 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6652478B1 (en) 1999-06-09 2003-11-25 The Procter & Gamble Company Intracutaneous edged microneedle apparatus
US6465709B1 (en) 1999-07-08 2002-10-15 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US9750897B2 (en) 1999-10-14 2017-09-05 Becton, Dickinson And Company Intradermal delivery device including a needle assembly
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
WO2001039822A1 (en) * 1999-12-03 2001-06-07 Mattern, Udo Device for injection of antiparasitic agents in pets
EP1104683A1 (en) * 1999-12-03 2001-06-06 Mattern, Udo Device for the injection of antiparasitic agents into pet animals
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
WO2001091846A3 (en) * 2000-05-26 2002-03-28 Procter & Gamble Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
WO2001091846A2 (en) * 2000-05-26 2001-12-06 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6406456B1 (en) 2000-06-08 2002-06-18 Avant Drug Delivery Systems, Inc. Jet injector
EP1161961A1 (en) * 2000-06-08 2001-12-12 Avant Drug Delivery Systems, Inc. Jet injector
US8998877B2 (en) 2000-06-29 2015-04-07 Becton, Dickinson And Company Intradermal delivery of substances
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US8986280B2 (en) 2000-06-29 2015-03-24 Becton, Dickinson And Company Intradermal delivery of substances
US9005182B2 (en) 2000-06-29 2015-04-14 Becton, Dickinson And Company Intradermal delivery of substances
US9242052B2 (en) 2000-06-29 2016-01-26 Becton, Dickinson And Company Method for altering drug pharmacokinetics based on medical delivery platform
US9339613B2 (en) 2000-06-29 2016-05-17 Becton, Dickinson And Company Intradermal delivery of substances
US8708994B2 (en) 2000-06-29 2014-04-29 Becton, Dickinson And Company Method for altering drug pharmacokinetics based on medical delivery platform
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6821281B2 (en) 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
EP1208858A1 (en) * 2000-11-27 2002-05-29 Paolo Versini Injector device for medical and cosmetic treatment
US7763203B2 (en) 2001-03-14 2010-07-27 Corium International, Inc. Method of manufacturing microneedle structures using photolithography
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
WO2002081014A1 (en) * 2001-04-06 2002-10-17 Glaxosmithkline Biologicals S.A. Hypodermic needle assembly
US6591124B2 (en) 2001-05-11 2003-07-08 The Procter & Gamble Company Portable interstitial fluid monitoring system
US8900186B2 (en) 2001-09-12 2014-12-02 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
US10661066B2 (en) 2001-09-12 2020-05-26 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
US7645263B2 (en) 2001-10-26 2010-01-12 Massachusetts Institute Of Technology Impedance sensor
US7429258B2 (en) 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
WO2003037407A1 (en) * 2001-10-26 2003-05-08 Massachusetts Institute Of Technology Transdermal transport device with suction
US7364568B2 (en) 2001-10-26 2008-04-29 Massachusetts Institute Of Technology Microneedle transdermal transport device
US7066922B2 (en) 2001-10-26 2006-06-27 Massachusetts Institute Of Technology Transdermal transport device with suction
US7651475B2 (en) 2001-10-26 2010-01-26 Massachusetts Institute Of Technology Microneedle transport device
US10322272B2 (en) 2002-05-06 2019-06-18 Becton, Dickinson And Company Method and device for controlling drug pharmacokinetics
US7722595B2 (en) 2002-05-06 2010-05-25 Becton, Dickinson And Company Method and device for controlling drug pharmacokinetics
US9192750B2 (en) 2002-05-06 2015-11-24 Becton, Dickinson And Company Method and device for controlling drug pharmacokinetics
US7828827B2 (en) 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
WO2004024211A3 (en) * 2002-09-12 2004-06-17 Childrens Hosp Medical Center Method and device for painless injection of medication
WO2004024211A2 (en) * 2002-09-12 2004-03-25 Children's Hospital Medical Center Method and device for painless injection of medication
US9682198B2 (en) 2003-08-28 2017-06-20 Becton, Dickinson And Company Intradermal injection device
EP2314282A2 (en) * 2003-10-24 2011-04-27 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
US7896841B2 (en) 2004-02-17 2011-03-01 Children's Hospital Medical Center Injection device for administering a vaccine
US7670314B2 (en) 2004-02-17 2010-03-02 Children's Hospital Medical Center Injection device for administering a vaccine
US9114238B2 (en) 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
US10238848B2 (en) 2007-04-16 2019-03-26 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US9452280B2 (en) 2007-04-16 2016-09-27 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US9498524B2 (en) 2007-04-16 2016-11-22 Corium International, Inc. Method of vaccine delivery via microneedle arrays
US9687641B2 (en) 2010-05-04 2017-06-27 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
US11419816B2 (en) 2010-05-04 2022-08-23 Corium, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
EP2608824A4 (en) * 2010-08-23 2017-11-08 Nanbu Plastics Co., Ltd. A percutaneous medication device and a needle formation used for the device
KR20140132714A (en) 2012-01-31 2014-11-18 가부시키가이샤 시세이도 Injection devices
CN104321101A (en) * 2012-01-31 2015-01-28 株式会社资生堂 Injection devices
WO2013113121A1 (en) * 2012-01-31 2013-08-08 Trichoscience Innovations Inc. Injection devices
KR20200019767A (en) 2012-01-31 2020-02-24 가부시키가이샤 시세이도 Injection devices
US9616182B2 (en) 2012-01-31 2017-04-11 Replicel Life Sciences Injection devices
US10463806B2 (en) 2012-01-31 2019-11-05 Replicel Life Sciences Injection devices
US11311684B2 (en) 2012-01-31 2022-04-26 Replicel Life Sciences Injection devices
WO2014004462A1 (en) * 2012-06-25 2014-01-03 Flugen, Inc. Multiple drug delivery device
US11052231B2 (en) 2012-12-21 2021-07-06 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
US10245422B2 (en) 2013-03-12 2019-04-02 Corium International, Inc. Microprojection applicators and methods of use
US11110259B2 (en) 2013-03-12 2021-09-07 Corium, Inc. Microprojection applicators and methods of use
US10195409B2 (en) 2013-03-15 2019-02-05 Corium International, Inc. Multiple impact microprojection applicators and methods of use
US11565097B2 (en) 2013-03-15 2023-01-31 Corium Pharma Solutions, Inc. Microarray for delivery of therapeutic agent and methods of use
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
US10384046B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
US11511051B2 (en) 2013-03-15 2022-11-29 Amgen Inc. Body contour adaptable autoinjector device
US9962534B2 (en) 2013-03-15 2018-05-08 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
WO2014143770A1 (en) * 2013-03-15 2014-09-18 Amgen Inc. Body contour adaptable autoinjector device
US10646664B2 (en) 2013-03-15 2020-05-12 Amgen Inc. Body contour adaptable autoinjector device
US10675452B2 (en) 2014-03-10 2020-06-09 3M Innovative Properties Company Micro-needle device
US11045612B2 (en) 2014-08-06 2021-06-29 Replicel Life Sciences Inc. Injection devices
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
WO2016112361A1 (en) * 2015-01-08 2016-07-14 University Of Washington Systems and methods for inhibiting heterotopic ossification
US10835689B2 (en) 2015-01-08 2020-11-17 University Of Washington Methods for inhibiting heterotopic ossification
CN104524669A (en) * 2015-01-14 2015-04-22 李洪湘 Multi-syringe-needle adsorption injection needle
US10583245B2 (en) 2015-02-17 2020-03-10 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
US11517663B2 (en) 2015-02-17 2022-12-06 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
AU2016220141B2 (en) * 2015-02-17 2018-07-12 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11129945B2 (en) 2016-06-06 2021-09-28 Sanofi-Aventis Deutschland Gmbh Auto-injector device
CN107213537A (en) * 2017-08-01 2017-09-29 上海市第人民医院 It is a kind of that servicing unit is precisely subcutaneously injected
TWI674121B (en) * 2018-08-30 2019-10-11 員全股份有限公司 Mini micro needle syringe

Also Published As

Publication number Publication date
NZ263619A (en) 1997-06-24
CA2159588A1 (en) 1994-10-27
IE68890B1 (en) 1996-07-24
EP0692989A1 (en) 1996-01-24
AU6436794A (en) 1994-11-08
JPH08508901A (en) 1996-09-24
IE930274A1 (en) 1994-10-19

Similar Documents

Publication Publication Date Title
WO1994023777A1 (en) Intradermal injection device
US6896670B2 (en) Safety injection device
US7497841B2 (en) Intradermal syringe and needle assembly
JP3816842B2 (en) Needleless jet infusion system with separate drug reservoir
EP0190477B1 (en) Body mounted pump housing and pump assembly employing the same
EP1660149B1 (en) Intradermal injection device
US8608684B2 (en) Impulse chamber for jet delivery device
JP2007514489A (en) Nozzle device having skin stretching means
JPH03501348A (en) preloaded automatic disposable syringe
JP2000515394A (en) Cartridge based drug delivery device
AU2013366011A1 (en) Fluid delivery device and method
US7217253B2 (en) Sequential impulse/delivery fluid medicament injector
JP6032892B2 (en) Cartridge stopper for intradermal administration system
JP3408814B2 (en) Vaccine distribution system
US5399170A (en) Syringe
GB2462669A (en) A syringe element for a needle-free injection apparatus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP NZ US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2159588

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 1995 532707

Country of ref document: US

Date of ref document: 19951006

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1994912055

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 263619

Country of ref document: NZ

WWP Wipo information: published in national office

Ref document number: 1994912055

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1994912055

Country of ref document: EP